Merit Medical Systems (MMSI) Rating Increased to Hold at BidaskClub

Merit Medical Systems (NASDAQ:MMSI) was upgraded by investment analysts at BidaskClub from a “sell” rating to a “hold” rating in a research report issued on Thursday.

MMSI has been the topic of a number of other research reports. ValuEngine lowered shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Wells Fargo & Co restated an “outperform” rating and issued a $51.00 target price (up previously from $46.00) on shares of Merit Medical Systems in a research report on Thursday, November 30th. Zacks Investment Research upgraded shares of Merit Medical Systems from a “hold” rating to a “buy” rating and set a $43.00 target price on the stock in a research report on Saturday, October 28th. SunTrust Banks set a $47.00 target price on shares of Merit Medical Systems and gave the company a “buy” rating in a research report on Thursday, November 16th. Finally, Canaccord Genuity restated a “buy” rating and issued a $45.00 target price on shares of Merit Medical Systems in a research report on Sunday, October 8th. Three investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. The company has an average rating of “Buy” and an average price target of $43.77.

Shares of Merit Medical Systems (NASDAQ:MMSI) opened at $46.80 on Thursday. Merit Medical Systems has a 52-week low of $24.23 and a 52-week high of $47.50. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.78 and a quick ratio of 1.43. The firm has a market cap of $2,274.01, a P/E ratio of 76.72, a price-to-earnings-growth ratio of 2.69 and a beta of 1.23.

Merit Medical Systems (NASDAQ:MMSI) last issued its earnings results on Wednesday, October 25th. The medical instruments supplier reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.30 by $0.02. Merit Medical Systems had a net margin of 4.06% and a return on equity of 9.86%. The firm had revenue of $179.30 million for the quarter, compared to analyst estimates of $181.28 million. During the same quarter last year, the business posted $0.26 earnings per share. The company’s quarterly revenue was up 14.2% on a year-over-year basis. equities research analysts expect that Merit Medical Systems will post 1.27 EPS for the current fiscal year.

In other news, Director Kent W. Stanger sold 2,918 shares of Merit Medical Systems stock in a transaction on Thursday, November 30th. The shares were sold at an average price of $44.55, for a total transaction of $129,996.90. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Franklin J. Miller sold 10,000 shares of Merit Medical Systems stock in a transaction on Saturday, December 29th. The stock was sold at an average price of $43.93, for a total transaction of $439,300.00. Following the transaction, the director now owns 21,244 shares in the company, valued at approximately $933,248.92. The disclosure for this sale can be found here. In the last quarter, insiders have sold 32,000 shares of company stock worth $1,416,379. 5.00% of the stock is owned by company insiders.

Several large investors have recently modified their holdings of the company. Suntrust Banks Inc. lifted its holdings in shares of Merit Medical Systems by 5.6% during the second quarter. Suntrust Banks Inc. now owns 7,847 shares of the medical instruments supplier’s stock worth $299,000 after purchasing an additional 414 shares during the period. Cornerstone Capital Management Holdings LLC. lifted its holdings in shares of Merit Medical Systems by 7.2% during the second quarter. Cornerstone Capital Management Holdings LLC. now owns 7,400 shares of the medical instruments supplier’s stock worth $282,000 after purchasing an additional 500 shares during the period. Ameritas Investment Partners Inc. lifted its holdings in shares of Merit Medical Systems by 20.9% during the second quarter. Ameritas Investment Partners Inc. now owns 4,272 shares of the medical instruments supplier’s stock worth $163,000 after purchasing an additional 738 shares during the period. Pinebridge Investments L.P. lifted its holdings in shares of Merit Medical Systems by 12.9% during the second quarter. Pinebridge Investments L.P. now owns 6,577 shares of the medical instruments supplier’s stock worth $251,000 after purchasing an additional 752 shares during the period. Finally, Louisiana State Employees Retirement System raised its stake in Merit Medical Systems by 6.4% during the fourth quarter. Louisiana State Employees Retirement System now owns 21,600 shares of the medical instruments supplier’s stock worth $933,000 after buying an additional 1,300 shares during the last quarter. Institutional investors own 90.60% of the company’s stock.

WARNING: “Merit Medical Systems (MMSI) Rating Increased to Hold at BidaskClub” was first posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this piece on another publication, it was copied illegally and reposted in violation of U.S. & international copyright & trademark law. The original version of this piece can be viewed at https://ledgergazette.com/2018/01/18/merit-medical-systems-mmsi-rating-increased-to-hold-at-bidaskclub.html.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Analyst Recommendations for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply